ArticleslgStudy

science

NL-201

NL-201 is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand NL-201 rather than just read about it. In short: NL-201 was an immunotherapy drug candidate that underwent a Phase 1 human clinical trial in cancer patients. It is a de novo protein that was first computationally designed at the Institute of Protein Design (IPD), University of Washington.

Key takeaways

  • NL-201 belongs to science; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect NL-201 to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of NL-201 from memory before moving on to harder problems.

Reference excerpt

NL-201 was an immunotherapy drug candidate that underwent a Phase 1 human clinical trial in cancer patients. It is a de novo protein that was first computationally designed at the Institute of Protein Design (IPD), University of Washington. In November 2022, Neoleukin Therapeutics announced it would discontinue the development of NL-201.

History The predecessor of NL-201, neoleukin-2/15, was first described and published on Nature magazine in January 2019. The citizen science distributed computing project Rosetta@home, based at the University of Washington, contributed with "forward folding" experiments that helped validate protein designs of neoleukin-2/15, from which NL-201 was further developed by Neoleukin Therapeutics, a biopharmaceutical company that originated at the IPD. The Phase 1 human clinical trial began on May 5, 2021. In January 2022, Neoleukin Therapeutics announced a collaboration with Merck for a combination clinical trial of Merck's Pembrolizumab and Neoleukin's NL-201. In November 2022, Neoleukin Therapeutics announced it would discontinue the development of NL-201.

References

Worked examples

Example 1 — a first encounter with NL-201

Start with the simplest possible case. Write down what NL-201 claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to NL-201 before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about NL-201 ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of NL-201

In research
NL-201 appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses NL-201 in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
NL-201 is common in secondary-school and first-year university syllabi. It links to neighbouring topics Antineoplastic and immunomodulating drug stubs, Experimental cancer drugs, Immunotherapy, so understanding it makes those chapters shorter.
In everyday life
Look for NL-201 outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study NL-201 in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what NL-201 means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain NL-201 out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is NL-201 in simple terms?

NL-201 was an immunotherapy drug candidate that underwent a Phase 1 human clinical trial in cancer patients. It is a de novo protein that was first computationally designed at the Institute of Protein Design (IPD), University of Washington.

Why does NL-201 matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study NL-201?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on NL-201.

Tags

  • Antineoplastic and immunomodulating drug stubs
  • Experimental cancer drugs
  • Immunotherapy

Keep exploring